Jasper Therapeutics, Inc. (JSPR) income statement
JSPRNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$11.52+1.18 (+11.41%)
Close on Nov 18, 2026Market cap $383.32MP/E –Yield –
Jasper Therapeutics, Inc. financial ratios
See a number that looks wrong?